Viatris Financial Statements
NASDAQ: VTRSHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Viatris revenue and earnings
In fiscal 2025, Viatris generated $14.30 billion in revenue, down 3.0% from fiscal 2024, its first annual decline since 2024. Viatris reported a net loss of $3.51 billion, compared with a loss of $634.2 million a year earlier. Gross margin was 35.1% (down from 38.2%) and operating margin -18.6%.
Diluted earnings per share came in at -$3.00. Over the last 5 fiscal years, VTRS's revenue has grown at a 3.7% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Viatris income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.30B | 14.74B | 15.43B | 16.26B | 17.89B | 11.95B | 11.50B | 11.43B |
| Revenue growth (YoY) | -2.98% | -4.46% | -5.14% | -9.08% | +49.73% | +3.87% | +0.58% | — |
| Cost of Revenue | 9.29B | 9.12B | 8.99B | 9.77B | 12.31B | 8.15B | 7.60B | 7.43B |
| Gross Profit | 5.01B | 5.62B | 6.44B | 6.50B | 5.58B | 3.80B | 3.90B | 4.00B |
| Operating Expenses | 7.68B | 5.61B | 5.67B | 4.88B | 5.61B | 4.01B | 3.18B | 3.10B |
| Research & Development | 965.90M | 808.70M | 805.20M | 662.20M | 751.10M | 555.10M | 639.90M | 704.50M |
| Selling, General & Admin | 3.79B | 4.10B | 4.07B | 4.18B | 4.53B | 3.34B | 2.56B | 2.44B |
| Operating Income | -2.66B | 10.10M | 766.20M | 1.61B | -34.00M | -210.80M | 715.50M | 905.60M |
| Interest Expense | 471.30M | 550.00M | 573.10M | 592.40M | 636.20M | 497.80M | 517.30M | 542.30M |
| Other Income (Expense) | -530.60M | -83.30M | 9.80M | 1.79B | 5.80M | -12.60M | -43.80M | -64.90M |
| Pretax Income | -3.67B | -623.20M | 202.90M | 2.81B | -664.40M | -721.20M | 154.40M | 298.40M |
| Income Tax | -150.10M | 11.00M | 148.20M | 734.60M | 604.70M | -51.30M | 137.60M | -54.10M |
| Net Income | -3.51B | -634.20M | 54.70M | 2.08B | -1.27B | -669.90M | 16.80M | 352.50M |
| Net Income growth (YoY) | — | -1259.41% | -97.37% | — | — | -4087.50% | -95.23% | — |
| EPS (Basic) | -3.00 | -0.53 | 0.05 | 1.71 | -1.05 | -1.11 | 0.03 | 0.69 |
| EPS (Diluted) | -3.00 | -0.53 | 0.05 | 1.71 | -1.05 | -1.11 | 0.03 | 0.68 |
| Shares Outstanding (Basic) | — | — | 1.20B | 1.21B | 1.21B | 601.20M | 515.70M | 514.50M |
| Shares Outstanding (Diluted) | — | — | 1.21B | 1.22B | 1.21B | 601.20M | 516.50M | 516.50M |
| EBITDA | 135.20M | 2.90B | 3.51B | 4.64B | 4.47B | 2.01B | 2.73B | 3.02B |
| Gross Margin | 35.06% | 38.15% | 41.74% | 39.95% | 31.17% | 31.78% | 33.89% | 35.00% |
| Operating Margin | -18.62% | 7.00% | 4.97% | 9.93% | -19.00% | -1.76% | 6.22% | 7.92% |
| Net Margin | -24.58% | -4.30% | 35.00% | 12.78% | -7.10% | -5.61% | 15.00% | 3.08% |
This table shows 8 annual periods of Viatris's income statement, from FY 2025 back to FY 2018, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow VTRS's reporting calendar. What is a income statement?